This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Efficacy and Safety of Fermented Velvet Antler Extract on Fatigue Recovery After Exercise

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2012 by Soo-Wan Chae, Chonbuk National University Hospital.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Soo-Wan Chae, Chonbuk National University Hospital
ClinicalTrials.gov Identifier:
NCT01689467
First received: September 18, 2012
Last updated: September 24, 2012
Last verified: September 2012
  Purpose
The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Fermented Velvet Antler extract on fatigue recovery after exercise. The investigators measured fatigue recovery parameters , including lactate, ammonia, inorganic phosphorus, creatine kinase and LDH, and monitored their blood pressure.

Condition Intervention Phase
Chronic Fatigue Syndrome Dietary Supplement: Fermented Velvet Antler extract Dietary Supplement: Placebo Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by Soo-Wan Chae, Chonbuk National University Hospital:

Primary Outcome Measures:
  • Changes in lactate [ Time Frame: 12 weeks ]
    Lactate was measured in study visit 1(0 week) and visit 3(12 week).

  • Changes in ammonia [ Time Frame: 12 weeks ]
    Ammonia was measured in study visit 1(0 week) and visit 3(12 week).

  • Changes in inorganic phosphorus [ Time Frame: 12 weeks ]
    Inorganic phosphorus was measured in study visit 1(0 week) and visit 3(12 week).

  • Changes in creatine kinase [ Time Frame: 12 weeks ]
    Creatine kinase was measured in study visit 1(0 week) and visit 3(12 week).

  • Changes in Lactage dehydrogenase(LDH) [ Time Frame: 12 weeks ]
    Lactage dehydrogenase(LDH) was measured in study visit 1(0 week) and visit 3(12 week).


Secondary Outcome Measures:
  • Changes in Multidimensional Fatigue Scale(MFS) [ Time Frame: 12 weeks ]
    Multidimensional Fatigue Scale(MFS) was measured in study visit 1(0 week) and visit 3(12 week).

  • Changes in 36-Item Short-Form Health Survey(SF-36) [ Time Frame: 12 weeks ]
    36-Item Short-Form Health Survey(SF-36) was measured in study visit 1(0 week) and visit 3(12 week).


Estimated Enrollment: 60
Study Start Date: June 2012
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Fermented Velvet Antler extract Dietary Supplement: Fermented Velvet Antler extract
Fermented Velvet Antler extract (1g/day)
Placebo Comparator: Placebo Dietary Supplement: Placebo
Placebo (1g/day)

  Eligibility

Ages Eligible for Study:   19 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Males and females 19-60 years old
  • Hemoglobin concentration between 13 and 14 g/dL(men), 12 and 13 g/dL(women)
  • Able to give informed consent

Exclusion Criteria:

  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
  • Participation in any other clinical trials within past 2 months
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • Pregnant or lactating women etc.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01689467

Contacts
Contact: Dal-Sik Kim, MD., PhD 82-63-250-1793 dskim@chonbuk.ac.kr
Contact: Eun-Ock Park, MS 82-63-250-2539 eopark@jbctc.org

Locations
Korea, Republic of
Clinical Trial Center for Functional Foods; Chonbuk National University Hospital Recruiting
Jeonju, Jeollabuk-do, Korea, Republic of, 560-822
Contact: Dal-Sik Kim, MD    82-63-250-1793    dskim@jbnu.ac.kr   
Sponsors and Collaborators
Chonbuk National University Hospital
  More Information

Responsible Party: Soo-Wan Chae, Clinical Trial Center for Functional Foods, Chonbuk National University Hospital
ClinicalTrials.gov Identifier: NCT01689467     History of Changes
Other Study ID Numbers: KD-FR-FVE
Study First Received: September 18, 2012
Last Updated: September 24, 2012

Additional relevant MeSH terms:
Fatigue
Fatigue Syndrome, Chronic
Signs and Symptoms
Virus Diseases
Muscular Diseases
Musculoskeletal Diseases
Encephalomyelitis
Central Nervous System Diseases
Nervous System Diseases
Neuromuscular Diseases

ClinicalTrials.gov processed this record on July 21, 2017